Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? is a research paper published in Neuro-Oncology (2024). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA120813
National Institutes of Health
Grant: NS120547
National Institutes of Health
Grant: NS122857
National Institutes of Health
Grant: NS124594
National Institutes of Health
Grant: CA275430
National Institutes of Health
Grant: CA221747
National Institutes of Health
Grant: CA272639
NCI NIH HHS
Grant: R01 CA120813
NCI NIH HHS
Grant: R01 CA275430
NCI NIH HHS
Grant: T32 CA009560
NINDS NIH HHS
Grant: R01 NS124594
NCI NIH HHS
Grant: P50 CA221747
NCI NIH HHS
Grant: R01 CA272639
NINDS NIH HHS
Grant: R01 NS122857
NINDS NIH HHS
Grant: R01 NS120547
FWCI
2.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals